FDG PET/CT is useful for the interim evaluation of response to therapy in patients affected by haematogenous spondylodiscitis

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 39, Issue 10, 2012, Pages 1538-1544

  Nanni, Cristina ^a   Boriani, Luca ^b   Salvadori, Caterina ^a   Zamparini, Eleonora ^a   Rorato, Giada ^a   Ambrosini, Valentina ^a   Gasbarrini, Alessandro ^b   Tumietto, Fabio ^a   Cristini, Francesco ^a   Scudeller, Luigia ^c   Boriani, Stefano ^b   Viale, Pierluigi ^a   Fanti, Stefano ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

^c FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

Early response to therapy; PET CT; Spondylodiscitis

Indexed keywords

ANTIBIOTIC AGENT; C REACTIVE PROTEIN; FLUORODEOXYGLUCOSE;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; CLINICAL ARTICLE; CLINICAL PRACTICE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DISKITIS; FEMALE; HEMATOGENOUS SPONDYLODISCITIS; HUMAN; INTERMETHOD COMPARISON; INTERVERTEBRAL DISK DEGENERATION; MALE; MYCOSIS; PROTEIN BLOOD LEVEL; PYOGENIC DISCITIS; SENSITIVITY AND SPECIFICITY; TREATMENT RESPONSE; TUBERCULAR INFECTION;

AGED; BACTERIAL INFECTIONS; C-REACTIVE PROTEIN; CERVICAL VERTEBRAE; DISCITIS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LUMBAR VERTEBRAE; MALE; MIDDLE AGED; MYCOSES; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; TREATMENT OUTCOME;

EID: 84868198334     PISSN: 16197070     EISSN: 16197089     Source Type: Journal    
DOI: 10.1007/s00259-012-2179-8     Document Type: Article

References (10)

1. Kirkman MA, Sridhar K. Posterior listhesis of a lumbar vertebra in spinal tuberculosis. Eur Spine J. 2011;20(1):1-5.
2. Viale P, Furlanut M, Scudeller L, Pavan F, Negri C, Crapis M, et al. Treatment of pyogenic (non-tuberculous) spondylodiscitis with tailored high-dose levofloxacin plus rifampicin. Int J Antimicrob Agents. 2009;33(4):379-82.
3. Rimmele T, Boselli E, Breilh D, Djabarouti S, Bel JC, Guyot R, et al. Diffusion of levofloxacin into bone and synovial tissues. J Antimicrob Chemother. 2004;53(3):533-5.
4. Murillo O, Domenech A, Garcia A, Tubau F, Cabellos C, Gudiol F, et al. Efficacy of high doses of levofloxacin in experimental foreign-body infection by methicillin-susceptible Staphylococcus aureus. Antimicrob Agents Chemother. 2006;50(12):4011-7.
5. Tascini C, Tagliaferri E, Di Paolo A, Ciofi L, Del Tacca M, Lambelet P, et al. Three-times weekly teicoplanin as outpatient treatment of chronic osteoarticular infections. J Chemother. 2009;21(4):421-5.
6. Garazzino S, Aprato A, Baietto L, D'Avolio A, Maiello A, De Rosa FG, et al. Glycopeptide bone penetration in patients with septic pseudoarthrosis of the tibia. Clin Pharmacokinet. 2008;47 (12):793-805.
7. Gouliouris T, Aliyu SH, Brown NM. Spondylodiscitis: update on diagnosis and management. J Antimicrob Chemother. 2010;65 Suppl 3:iii11-24.
8. Zilkens KW, Peters KM, Schwanitz BM. New inflammation markers for early detection of spondylodiscitis. Eur Spine J. 1992;1(3):152-5.
9. Ohtori S, Suzuki M, Koshi T, Yamashita M, Yamauchi K, Inoue G, et al. 18F-fluorodeoxyglucose-PET for patients with suspected spondylitis showing Modic change. Spine. 1976;35(26):E1599-603.
10. Albert H, Pedersen H, Manniche C, Hoilund-Carlsen PF. PET imaging in patients with Modic changes. Nuklearmedizin. 2009;48(3):110-2.